171 related articles for article (PubMed ID: 38134062)
21. Hepatocellular carcinoma as a leading cause of cancer-related deaths in Japanese type 2 diabetes mellitus patients.
Shima T; Uto H; Ueki K; Kohgo Y; Yasui K; Nakamura N; Nakatou T; Takamura T; Kawata S; Notsumata K; Sakai K; Tateishi R; Okanoue T
J Gastroenterol; 2019 Jan; 54(1):64-77. PubMed ID: 30006904
[TBL] [Abstract][Full Text] [Related]
22. Long-term risks of cardiovascular death in a population-based cohort of 1,141,675 older patients with cancer.
Guan T; Jiang Y; Luo Z; Liang Y; Feng M; Lu Z; Yi M; Teng Y; Zhou R; Zeng L; Chi K; Ou C; Chen M
Age Ageing; 2023 May; 52(5):. PubMed ID: 37192506
[TBL] [Abstract][Full Text] [Related]
23. The role of pre-existing diabetes mellitus on hepatocellular carcinoma occurrence and prognosis: a meta-analysis of prospective cohort studies.
Yang WS; Va P; Bray F; Gao S; Gao J; Li HL; Xiang YB
PLoS One; 2011; 6(12):e27326. PubMed ID: 22205924
[TBL] [Abstract][Full Text] [Related]
24. The occurrence of hepatocellular carcinoma in different risk stratifications of clinically noncirrhotic nonalcoholic fatty liver disease.
Lee TY; Wu JC; Yu SH; Lin JT; Wu MS; Wu CY
Int J Cancer; 2017 Oct; 141(7):1307-1314. PubMed ID: 28509327
[TBL] [Abstract][Full Text] [Related]
25. High incidence of hepatocellular carcinoma and cirrhotic complications in patients with psychiatric illness: a territory-wide cohort study.
Yip TC; Wong GL; Tse YK; Yuen BW; Luk HW; Lam MH; Li MK; Loo CK; Tsang OT; Tsang SW; Chan HL; Wing YK; Wong VW
BMC Gastroenterol; 2020 Apr; 20(1):128. PubMed ID: 32349708
[TBL] [Abstract][Full Text] [Related]
26. Synergistic effects of family history of hepatocellular carcinoma and hepatitis B virus infection on risk for incident hepatocellular carcinoma.
Loomba R; Liu J; Yang HI; Lee MH; Lu SN; Wang LY; Iloeje UH; You SL; Brenner D; Chen CJ;
Clin Gastroenterol Hepatol; 2013 Dec; 11(12):1636-45.e1-3. PubMed ID: 23669307
[TBL] [Abstract][Full Text] [Related]
27. Patients with hepatocellular carcinoma from more rural and lower-income households have more advanced tumor stage at diagnosis and significantly higher mortality.
Wong RJ; Kim D; Ahmed A; Singal AK
Cancer; 2021 Jan; 127(1):45-55. PubMed ID: 33103243
[TBL] [Abstract][Full Text] [Related]
28. Ultrasound screening and risk factors for death from hepatocellular carcinoma in a high risk group in Taiwan.
Chen TH; Chen CJ; Yen MF; Lu SN; Sun CA; Huang GT; Yang PM; Lee HS; Duffy SW
Int J Cancer; 2002 Mar; 98(2):257-61. PubMed ID: 11857416
[TBL] [Abstract][Full Text] [Related]
29. Age-specific cardiovascular disease-related mortality among patients with major gastrointestinal cancers: A SEER population-based study.
Liu G; Zhang BF
Cancer Med; 2023 Aug; 12(16):17253-17265. PubMed ID: 37387603
[TBL] [Abstract][Full Text] [Related]
30. Hepatocellular carcinoma associated with membranous obstruction of the inferior vena cava: incidence, characteristics, and risk factors and clinical efficacy of TACE.
Gwon D; Ko GY; Yoon HK; Sung KB; Kim JH; Lee SS; Lee JM; Ohm JY; Shin JH; Song HY
Radiology; 2010 Feb; 254(2):617-26. PubMed ID: 20093533
[TBL] [Abstract][Full Text] [Related]
31. Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis.
Bolondi L; Sofia S; Siringo S; Gaiani S; Casali A; Zironi G; Piscaglia F; Gramantieri L; Zanetti M; Sherman M
Gut; 2001 Feb; 48(2):251-9. PubMed ID: 11156649
[TBL] [Abstract][Full Text] [Related]
32. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.
Chiaramonte M; Stroffolini T; Vian A; Stazi MA; Floreani A; Lorenzoni U; Lobello S; Farinati F; Naccarato R
Cancer; 1999 May; 85(10):2132-7. PubMed ID: 10326690
[TBL] [Abstract][Full Text] [Related]
33. Trends in Incidences and Risk Factors for Hepatocellular Carcinoma and Other Liver Events in HIV and Hepatitis C Virus-coinfected Individuals From 2001 to 2014: A Multicohort Study.
Gjærde LI; Shepherd L; Jablonowska E; Lazzarin A; Rougemont M; Darling K; Battegay M; Braun D; Martel-Laferriere V; Lundgren JD; Rockstroh JK; Gill J; Rauch A; Mocroft A; Klein MB; Peters L
Clin Infect Dis; 2016 Sep; 63(6):821-829. PubMed ID: 27307505
[TBL] [Abstract][Full Text] [Related]
34. Long-term and short-term cardiovascular disease mortality among patients of 21 non-metastatic cancers.
Guan T; Monteiro O; Chen D; Luo Z; Chi K; Li Z; Liang Y; Lu Z; Jiang Y; Yang J; Lin W; Yi M; Zhang K; Ou C
J Adv Res; 2024 Mar; ():. PubMed ID: 38537701
[TBL] [Abstract][Full Text] [Related]
35. Epidemiology, clinical-treatment patterns and outcome in 256 hepatocellular carcinoma cases.
Fenoglio L; Serraino C; Castagna E; Cardellicchio A; Pomero F; Grosso M; Senore C
World J Gastroenterol; 2013 Jun; 19(21):3207-16. PubMed ID: 23745022
[TBL] [Abstract][Full Text] [Related]
36. Posttransplant Outcomes in Older Patients With Hepatocellular Carcinoma Are Driven by Non-Hepatocellular Carcinoma Factors.
Adeniji N; Arjunan V; Prabhakar V; Mannalithara A; Ghaziani T; Ahmed A; Kwo P; Nguyen M; Melcher ML; Busuttil RW; Florman SS; Haydel B; Ruiz RM; Klintmalm GB; Lee DD; Burcin Taner C; Hoteit MA; Verna EC; Halazun KJ; Tevar AD; Humar A; Chapman WC; Vachharajani N; Aucejo F; Nydam TL; Markmann JF; Mobley C; Ghobrial M; Langnas AN; Carney CA; Berumen J; Schnickel GT; Sudan DL; Hong JC; Rana A; Jones CM; Fishbein TM; Agopian V; Dhanasekaran R
Liver Transpl; 2021 May; 27(5):684-698. PubMed ID: 33306254
[TBL] [Abstract][Full Text] [Related]
37. Cardiovascular disease-specific mortality in 270,618 patients with non-small cell lung cancer.
Sun JY; Zhang ZY; Qu Q; Wang N; Zhang YM; Miao LF; Wang J; Wu LD; Liu Y; Zhang CY; Wang RX
Int J Cardiol; 2021 May; 330():186-193. PubMed ID: 33581175
[TBL] [Abstract][Full Text] [Related]
38. Treatment with direct-acting antivirals for HCV decreases but does not eliminate the risk of hepatocellular carcinoma.
Piñero F; Mendizabal M; Ridruejo E; Herz Wolff F; Ameigeiras B; Anders M; Schinoni MI; Reggiardo V; Palazzo A; Videla M; Alonso C; Santos L; Varón A; Figueroa S; Vistarini C; Adrover R; Fernández N; Perez D; Tanno F; Hernández N; Sixto M; Borzi S; Bruno A; Cocozzella D; Soza A; Descalzi V; Estepo C; Zerega A; de Araujo A; Cheinquer H; Silva M;
Liver Int; 2019 Jun; 39(6):1033-1043. PubMed ID: 30636361
[TBL] [Abstract][Full Text] [Related]
39. Large-scale long-term follow-up study of Japanese patients with non-alcoholic Fatty liver disease for the onset of hepatocellular carcinoma.
Kawamura Y; Arase Y; Ikeda K; Seko Y; Imai N; Hosaka T; Kobayashi M; Saitoh S; Sezaki H; Akuta N; Suzuki F; Suzuki Y; Ohmoto Y; Amakawa K; Tsuji H; Kumada H
Am J Gastroenterol; 2012 Feb; 107(2):253-61. PubMed ID: 22008893
[TBL] [Abstract][Full Text] [Related]
40. Risk of hepatocellular carcinoma in Danish outpatients with alcohol-related cirrhosis.
Jepsen P; Kraglund F; West J; Villadsen GE; Sørensen HT; Vilstrup H
J Hepatol; 2020 Nov; 73(5):1030-1036. PubMed ID: 32512015
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
